계명대학교 의학도서관 Repository

Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome

Metadata Downloads
Author(s)
Sohyeon ParkIn-Cheol KimHyungseop KimYun-Kyeong ChoCheol Hyun LeeSeung-Ho Hur
Keimyung Author(s)
Kim, In CheolKim, Hyung SeopCho, Yun KyeongLee, Cheol HyunHur, Seung Ho
Department
Dept. of Internal Medicine (내과학)
Journal Title
Heart Vessels
Issued Date
2022
Volume
37
Keyword
Soluble ST2RemodelingAcute coronary syndromeHeart failure
Abstract
The association of the soluble suppression of tumorigenicity 2 (sST2) and the prognosis of heart failure have been well evaluated. However, little is known about the prediction of sST2 for left ventricular (LV) remodeling in acute coronary syndrome (ACS). We investigated the ability of sST2 to predict LV remodeling following the revascularization of ACS. From May 2019 to December 2020, 95 patients with LV ejection fraction (EF) < 50% who underwent coronary revascularization for ACS (unstable angina, non-ST-elevation myocardial infarction, ST-elevation myocardial infarction) were enrolled. Echocardiography and sST2 were performed at baseline and at a 3-month follow-up. The association between LV remodeling, using the end-diastolic volume index, and sST2 at baseline and at the 3-month follow-up, and the difference between each value was explored. During follow-up, 41 patients showed LV adverse remodeling. The baseline sST2 increased in patients without adverse remodeling (32.05 ng/mL vs. 23.5 ng/mL, p < 0.001), although clinical characteristics were similar between the two groups. During the mean follow-up of 3 months, a significant correlation was found in the changes between sST2 and LV end-diastolic/systolic volume index (r = 0.649; p < 0.001, r = 0.618; p < 0.001, respectively), but not in the changes of LVEF (r = − 0.132, p = 0.204). The use of angiotensin-converting enzyme 2 inhibitors/receptor blockers was higher (90.7% vs. 53.7%, p < 0.001) and sST2 decreased more predominantly in patients without adverse remodeling (23.18 ng/mL vs 26.40 ng/mL, p = 0.003). However, the changes in sST2 and LV volume were not different according to the ACS types (p > 0.05, for all). Estimates of the odds ratio (OR) for remodeling according to the sST2 difference increased substantially with a negative increase in the sST2 difference. Multivariable analysis found that, the difference between the baseline and 3-month sST2 was the most important determinant of LV remodeling following the revascularization of ACS (OR 1.24; 95% confidence interval: 1.09 to 1.41; p = 0.001). In conclusion, an increase in sST2 during follow-up was a useful predictor of LV remodeling.
Keimyung Author(s)(Kor)
김인철
김형섭
조윤경
이철현
허승호
Publisher
School of Medicine (의과대학)
Citation
Sohyeon Park et al. (2022). Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome. Heart Vessels, 37, 173–183. doi: 10.1007/s00380-021-01905-z
Type
Article
ISSN
1615-2573
Source
https://link.springer.com/article/10.1007%2Fs00380-021-01905-z
DOI
10.1007/s00380-021-01905-z
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43946
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Authorize & License
  • Authorize공개
  • EmbargoForever
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.